The Slowave Movement Wants To Disrupt The Way We Think About Sleep
Sometime in the summer of 2013, a New York City-based writer named Fiona Duncan began noticing an abundance of jeans, fleece and sneakers in the historically fashion-fanatic neighborhood known as Soho. To help explain the unnerving prevalence of "stylized blandness" and "dad-brand non-style" hanging about, she borrowed -- and subsequently popularized -- a term that's all but commonplace now: normcore. The term is simple and concise, easily packaged next to a pound sign, ready to fall from the lips of a trendy teen. Adidas tennis shoes, "Seinfeld" and President Obama all became part and parcel of the normcor...
Source: Healthy Living - The Huffington Post - April 14, 2016 Category: Consumer Health News Source Type: news
Endurance expert: Drugs could help 'lazy' people exercise
(University of Kent) Together with lack of time, physical exertion is one of the main perceived barriers to exercise. This is not surprising because humans evolved to be 'lazy', i.e. to conserve energy. Professor Samuele Marcora suggests that reducing perception of effort during exercise using caffeine or other psychoactive drugs (e.g. methylphenidate and modafinil) could help many people stick to their fitness plans. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 3, 2015 Category: Biology Source Type: news
What’s the deal with modafinil? | Archy de Berker and Sven Bestmann
Recent hype surrounding neuroenhancing drugs should set alarm bells ringing for scientists A great deal of excitement has been generated in recent weeks by a review paper examining the literature on the drug modafinil, which concluded that “modafinil may well deserve the title of the first well-validated pharmaceutical ‘nootropic’ [cognitive enhancing] agent”. Coverage in the Guardian, Telegraph, British Medical Journal, and the Independent all called attention to the work, with a press release from Oxford University trumpeting “Review of ‘smart drug’ shows modafinil does enhance cognition”. Related: Is mod...
Source: Guardian Unlimited Science - October 5, 2015 Category: Science Authors: Archy de Berker and Sven Bestmann Tags: Science Psychology Drugs Medical research Source Type: news
Don’t judge politicians by their taste in vests | Letters
Gladstone collars, Anthony Eden hats, Wilson’s raincoats – now it’s Jeremy Corbyn vests. Why are male politicians judged by their clothing rather than their policies and principles?Robert SolomonLondon• While there is outrage at taking drugs to improve athletic performance, apparently it’s fine to take drugs to improve academic performance (Modafinil hailed as the first safe “smart drug”, 20 August).Jonathan LongLeeds Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 24, 2015 Category: Science Authors: Letters Tags: Jeremy Corbyn Drugs in sport Genetics Source Type: news
Does "smart drug" really help people focus?
Many students pop modafinil thinking it will help them cram for finals, but evidence was lacking (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 20, 2015 Category: Consumer Health News Source Type: news
Why taking smart drugs just isn't very clever
As medical advances endow us with superhuman abilities, we are in danger of losing our humanity (Source: Telegraph Health)
Source: Telegraph Health - August 20, 2015 Category: Consumer Health News Tags: university provigil oxbridge narcolepsy modafinil students oxford smart drugs cambridge Source Type: news
The Truth About This So-Called 'Smart Drug'
By: Laura Geggel Published: 08/19/2015 07:55 PM EDT on LiveScience The "smart drug" modafinil actually does work for some people, improving their performance on long and complex tasks, also enhancing decision-making and planning skills, a new review of studies finds. Modafinil, also known by its brand name Provigil, is approved by the Food and Drug Administration to treat people with sleep disorders such as narcolepsy. But the majority of the drug's users — such as students who take it to study for exams — use it off-label, believing it may help them focus. This is despite the lack of strong evidence to date sh...
Source: Science - The Huffington Post - August 20, 2015 Category: Science Source Type: news
Smart drug Modafinil does work improving memory and learning
The findings raise serious ethical questions about whether modafinil should be ‘classified, condoned or condemned’, University of Oxford and Harvard Medical School experts said. (Source: the Mail online | Health)
Source: the Mail online | Health - August 20, 2015 Category: Consumer Health News Source Type: news
'Smart drug' taken by one in four students really does boost performance
Scientists say it is time to have an ethical debate about whether Modafinil should be 'condoned or condemned.' (Source: Telegraph Health)
Source: Telegraph Health - August 19, 2015 Category: Consumer Health News Tags: Modafinil harvard students oxford smart drug Source Type: news
Narcolepsy medication modafinil is world's first safe 'smart drug'
Increasingly taken by healthy people to improve focus before exams, after a comprehensive review researchers say modafinil is safe in the short-term Modafinil is the world’s first safe “smart drug”, researchers at Harvard and Oxford universities have said, after performing a comprehensive review of the drug. They concluded that the drug, which is prescribed for narcolepsy but is increasingly taken without prescription by healthy people, can improve decision- making, problem-solving and possibly even make people think more creatively.While acknowledging that there was limited information available on the effects of lo...
Source: Guardian Unlimited Science - August 19, 2015 Category: Science Authors: Helen Thomson Tags: Drugs Science Neuroscience Source Type: news
Narcolepsy medication modafinil is world's first safe 'smart drug'
Increasingly taken by healthy people to improve focus before exams, after a comprehensive review researchers say modafinil is safe in the short-termModafinil is the world ’s first safe “smart drug”, researchers at Harvard and Oxford universities have said, after performing a comprehensive review of the drug. They concluded that the drug, which is prescribed for narcolepsy but is increasingly taken without prescription by healthy people, can improve decision- ma king, problem-solving and possibly even make people think more creatively.While acknowledging that there was limited information available onthe effects of lo...
Source: Guardian Unlimited Science - August 19, 2015 Category: Science Authors: Helen Thomson Tags: Drugs Science Neuroscience Source Type: news
With A $1.2 Billion Hammer, The FTC Closes Loophole To Prevent Generic Drugs
This morning, the U.S. Federal Trade Commission drew blood: Teva Pharmaceuticals will pay $1.2 billion to reimburse insurers, drug wholesalers, and pharmacies who paid full price for the Provigil, produced by Cephalon, a company Teva bought in 2011, because Cephalon had paid generic drugmakers to delay launching cheaper versions of (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 30, 2015 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
Teva, FTC Reach $1.2 Billion Settlement
Teva Pharmaceutical Industries will pay $1.2 billion to settle government allegations its Cephalon subsidiary paid generic-drug makers to delay competing versions of the sleep-disorder drug Provigil. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 29, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion
The agency accused the company of illegally blocking generic competition to Provigil, a sleep-disorder drug. (Source: NYT Health)
Source: NYT Health - May 28, 2015 Category: Consumer Health News Authors: REBECCA R. RUIZ and KATIE THOMAS Tags: Provigil Drugs (Pharmaceuticals) Federal Trade Commission Consumer Protection Cephalon Inc. Source Type: news
Teva reaches $1.2B settlement with the FTC
Teva Pharmaceuticals Industries has agreed to pay $1.2 billion to settle charges that Chester County-based Cephalon, which Teva acquired in 2011, illegally blocked the launch of generic versions of its sleep disorder drug Provigil.
The settlement reached with the Federal Trade Commission is part of the agency's ongoing efforts to crackdown on "pay-for-delay" deals, under which the makers of brand name prescription drug products allegedly work out agreements with generic drug pharmaceuticals to delay… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 28, 2015 Category: American Health Authors: John George Source Type: news
